marijuana stocks

Cara reports 4Q loss

Cara Therapeutics posts loss of $4.2 million in 4th quarter

SHELTON, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Thursday reported a fourth-quarter loss of $4.2 million, after reporting a profit in the same period a year earlier.

The Shelton, Connecticut-based company said it had a loss of 18 cents per share.

The biotechnology company posted revenue of $914,000 in the period.

For the year, the company reported that its loss widened to $17.7 million, or 85 cents per share. Revenue was reported as $3.2 million.

Cara shares have fallen nearly 7 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.30, a drop of 45 percent in the last 12 months.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA

_____

Keywords: Cara Therapeutics, Earnings Report


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

 4Front Ventures Corp. (FFNTF) Fiscal Second Quarter 2020 Earnings Date and Conference Call

4Front Announces Fiscal Second Quarter 2020 Earnings Date and Conference Call 4Front…

SOL Global Investments Corp. (SOLCF) Continues Principal Re-Payments Towards $50 Million Credit Facility

SOL Global Continues Principal Re-Payments Towards $50 Million Credit Facility SOL Global…

Ionic Brands Corp (IONC.CN) secures two cannabis-infused coffee patents

Ionic secures two cannabis-infused coffee patents Ionic Brands Corp. is advancing into…

$INSY Announces Its Naloxone Sublingual Spray Received Fast Track Designation

Insys Therapeutics Announces Its Naloxone Sublingual Spray Received Fast Track Designation From…